GOODWILL AND OTHER INTANGIBLE ASSETS

3 Months Ended

Sep. 30, 2015

GOODWILL AND OTHER INTANGIBLE ASSETS

NOTE 3 — GOODWILL AND OTHER INTANGIBLE ASSETS

The following table presents goodwill by product category and the related change in the carrying amount:

(In millions)	Skin Care			Makeup		Fragrance			Hair Care			Total

Balance as of June 30, 2015
Goodwill	$	183.9		$	449.7	$	181.3		$	394.7		$	1,209.6
Accumulated impairments	(29.1		)	—		—			(35.7		)	(64.8		)

	154.8			449.7		181.3			359.0			1,144.8


Goodwill acquired during the period	—			2.5		—			—			2.5
Translation adjustments	0.1			—		(1.4		)	(1.2		)	(2.5		)

	0.1			2.5		(1.4		)	(1.2		)	—


Balance as of September 30, 2015
Goodwill	184.2			452.2		179.9			391.5			1,207.8
Accumulated impairments	(29.3		)	—		—			(33.7		)	(63.0		)

	$	154.9		$	452.2	$	179.9		$	357.8		$	1,144.8

Other intangible assets consist of the following:

	September 30, 2015						June 30, 2015
(In millions)	Gross Carrying Value		Accumulated Amortization		Total Net Book Value		Gross Carrying Value		Accumulated Amortization		Total Net Book Value

Amortizable intangible assets:
Customer lists and other	$	294.1	$	232.3	$	61.8	$	294.4	$	228.7	$	65.7
License agreements	43.0		43.0		—		43.0		43.0		—

	$	337.1	$	275.3	61.8		$	337.4	$	271.7	65.7

Non-amortizable intangible assets:
Trademarks and other					260.1						260.9

Total intangible assets					$	321.9					$	326.6

The aggregate amortization expense related to amortizable intangible assets was $3.7 million and $3.0 million for the three months ended September 30, 2015 and 2014, respectively. The estimated aggregate amortization expense for the remainder of fiscal 2016 and for each of fiscal 2017 to 2020 is $11.7 million, $13.3 million, $11.8 million, $11.0 million and $4.0 million, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details